{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-020163","form_type":"8-K","ticker":"LIXT","cik":"0001335105","company_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","filed_at":"2023-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.489848+00:00","generated_at":"2026-06-14T06:26:01.170632+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Lixte Biotechnology Holdings effects 1-for-10 reverse stock split","bullets":["Reverse stock split effective June 2, 2023; every 10 shares combined into 1.","Stockholders approved the split at a Special Meeting on May 26, 2023.","Common stock begins trading on Nasdaq on a split-adjusted basis June 5, 2023.","No fractional shares issued; any fractional share rounded up to nearest whole share.","Proportionate adjustments made to options, warrants, and Series A Preferred conversion."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-020163","json":"https://secwatch.observer/filing/0001493152-23-020163.json","markdown":"https://secwatch.observer/filing/0001493152-23-020163.md","text":"https://secwatch.observer/filing/0001493152-23-020163.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1335105/000149315223020163/0001493152-23-020163-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1335105/000149315223020163/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T06:26:01.170632+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"12917c3030012b849c5c39b16d1caee14999328f","claim":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.: Filed a Certificate of Amendment to the Certificate of Incorporation to effect a 1-for-10 reverse stock split of common stock, effective June 2, 2023 (effective 2023-06-02).","evidence_excerpt":"On June 1, 2023, Lixte Biotechnology Holdings, Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-10 reverse stock split of its outstanding shares of common stock. The Amendment was effective on June 2, 2023 (the “Effective Time”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315223020163/0001493152-23-020163-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-06-02"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}